Albion Financial Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11 | Hold |
5
| – | – | ﹤0.01% | 583 |
|
|
2025
Q1 | $9 | Hold |
5
| – | – | ﹤0.01% | 605 |
|
|
2024
Q4 | $10 | Hold |
5
| – | – | ﹤0.01% | 679 |
|
|
2024
Q3 | $29 | Hold |
5
| – | – | ﹤0.01% | 504 |
|
|
2024
Q2 | $41 | Hold |
5
| – | – | ﹤0.01% | 504 |
|
|
2024
Q1 | $70 | Buy |
+5
| New | +$70 | ﹤0.01% | 493 |
|
|
2023
Q4 | – | Sell |
-5
| Closed | -$25 | – | 486 |
|
|
2023
Q3 | $25 | Hold |
5
| – | – | ﹤0.01% | 470 |
|
|
2023
Q2 | $29 | Hold |
5
| – | – | ﹤0.01% | 467 |
|
|
2023
Q1 | $52 | Hold |
5
| – | – | ﹤0.01% | 440 |
|
|
2022
Q4 | $98 | Hold |
5
| – | – | ﹤0.01% | 474 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 503 |
|
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 574 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 626 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 648 |
|
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 533 |
|
|
2021
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 485 |
|
|
2020
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 452 |
|